pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Integrative Oncology Proven to Ease Cancer Symptoms, Yet Insurance Still Refuses Coverage

Sep 22, 2026·read at STAT ↗Negative

Professor Lorenzo Cohen, a distinguished integrative oncology researcher and melanoma survivor, argues that the science supporting symptom-relieving therapies for cancer patients is well established.

Studies show that acupuncture can lessen chemotherapy-induced nausea, while structured exercise, nutrition counseling and mindfulness programs improve pain, fatigue, anxiety and even immune function.

Despite this evidence, most insurers refuse to reimburse these complementary approaches, leaving doctors and patients to accept limited options. Cohen calls the gap indefensible and urges payers to align coverage with the proven benefits of integrative care.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?”

read at STAT ↗
1,517 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLE
topics
Oncology40Immunology6Pain6Melanoma3Major Depression2DermatologyEndocrinology & MetabolismHepatologyNSCLCPulmonology

related stories

  • 31m agoBMS says goodbye to 265 New Jersey staff as reorg rolls onBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Aug 55 NextGen winners who went public this year (and which ones are hiring)BioSpace
  • May 11Dr Randall on the Rationale for Investigating CSF-1R Inhibition in TGCTonclive
  • May 9The OncFive: Top Oncology Articles for the Week of 5/3onclive